AUG 19, 2021 6:00 AM PDT

Immune Enzyme Kills Viruses but Makes Tumors Stronger

WRITTEN BY: Tara Fernandez

Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respected doctor by day and whose darker side manifests involuntarily at night. 

The immune enzyme APOBEC3A also has a similar dual nature: it helps shield healthy cells against viral infections and induces dangerous mutations in cancer cells, resulting in cancer metastasis and drug resistance. 

In a recent study, molecular immunologists at the University of California, Irvine have unraveled some of APOBEC3A’s long-standing mysteries, revealing two distinct pathways by which cells regulate the enzyme’s expression.

Previously, the team demonstrated how DNA mutations initiated by APOBEC3A—where the enzyme launches an attack on cancer cell genomes in a bid to stop them from growing—are incredibly common. Researchers detected these mutation signatures in over 80 percent of lung and breast cancers, for example.

In their latest work, the scientists took a closer look into how viral infections and stress caused by chemotherapeutic drugs influenced the activity of APOBEC3A. They found that viral infections kickstarted specific immune response pathways that upregulated APOBEC3, resulting in the elimination of viral pathogens. However, chemotherapy stimulates a distinct immune response which causes APOBEC3A to induce mutations in cancer cells, making them more aggressive.

“By understanding how cancer cells and viral infections regulate APOBEC3A expression, we are poised to take a critical step forward toward the development of both new therapeutic strategies to fight cancer and new antiviral therapies,” commented Rémi Buisson, lead investigator on the study.

In future works, Buisson and colleagues plan to study APOBEC3A’s role in the body’s fight against SARS-CoV-2, the virus that causes COVID-19. They are also looking to develop strategies for preventing APOBEC3A-induced mutations in tumors to improve the efficacy of anticancer treatments.

 



Sources: Nature Communications, UCI School of Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 27, 2021
Health & Medicine
No Link Found Between Vaccinations and Increased Risk of Allergic Diseases
JUL 27, 2021
No Link Found Between Vaccinations and Increased Risk of Allergic Diseases
It is well known that allergies and asthma have been on the rise in developed nations where childhood mass vaccinations ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
AUG 27, 2021
Health & Medicine
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
AUG 27, 2021
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
Since their discovery, there has been an interest in how ABO blood groups and infectious diseases may be related. In add ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
SEP 09, 2021
Drug Discovery & Development
Can vaccines help prevent and treat opioid addiction?
SEP 09, 2021
Can vaccines help prevent and treat opioid addiction?
According to the United States Centers for Disease Control (CDC), 136 people die from an opioid overdose every ...
OCT 05, 2021
Immunology
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
OCT 05, 2021
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
Months after COVID symptoms have subsided, some individuals continue to grapple with the lingering effects of the infect ...
Loading Comments...